Early research (Phase 1)UnknownNCT05475847What this trial is testingStudy of C-TIL052A Cell Therapy in Advanced Cervical CancerWho this might be right forCervical Cancer Fudan University 20
Early research (Phase 1)Ended earlyNCT03277482What this trial is testingDurvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerWho this might be right forRecurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)Looking for participantsNCT05512208What this trial is testingAvutometinib (VS-6766) Plus DefactinibWho this might be right forEndometrioid CancerMucinous Ovarian CancerHigh Grade Serous Ovarian Cancer+2 more University of Oklahoma 55
Not applicableLooking for participantsNCT06781151What this trial is testingExplore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTBWho this might be right forOvarian Cancer RecurrentEndometrial Cancer RecurrentCervical Cancer Recurrent Sun Yat-sen University 200
Testing effectiveness (Phase 2)Looking for participantsNCT05803018What this trial is testingBL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological MalignanciesWho this might be right forGynecological Malignant TumorSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT01891344What this trial is testingRucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)Who this might be right forOvarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more pharmaand GmbH 491
Early research (Phase 1)Study completedNCT00770536What this trial is testingAMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CRWho this might be right forCancerCarcinomaFallopian Tube Cancer+6 more Amgen 103
Testing effectiveness (Phase 2)Looking for participantsNCT06769152What this trial is testingA Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant TumorsWho this might be right forCervical CancerOvarian Cancer Shanghai Henlius Biotech 130
Testing effectiveness (Phase 2)Looking for participantsNCT06023862What this trial is testingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Who this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more Yonsei University 198
Testing effectiveness (Phase 2)Ended earlyNCT01184053What this trial is testingTrisenox® in Women With Metastatic Endometrial CancerWho this might be right forEndometrial Carcinoma UNC Lineberger Comprehensive Cancer Center 3
Not applicableStudy completedNCT03270995What this trial is testingCognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT StudyWho this might be right forBreast NeoplasmsOvarian NeoplasmsEndometrial Neoplasms+1 more McGill University 144
Early research (Phase 1)Study completedNCT00268918What this trial is testingDocetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsWho this might be right forOvarian CancerEndometrial CancerCervical Cancer+3 more Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)UnknownNCT04699071What this trial is testingTrial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)Who this might be right forAdenocarcinomasRecurrent Gynecological National University Hospital, Singapore 10
Testing effectiveness (Phase 2)Study completedNCT01079832What this trial is testingStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological MalignanciesWho this might be right forFallopian Tube CancerOvarian SarcomaOvarian Stromal Cancer+23 more Case Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01482715What this trial is testingOral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)Who this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer+1 more pharmaand GmbH 136
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00545792What this trial is testingSafety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological CancersWho this might be right forCervical CancerEndometrial CancerOvarian Cancer+2 more Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT03926936What this trial is testingFUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia StudyWho this might be right forEndometrial Stromal SarcomaAdenosarcoma of UterusLeiomyosarcoma Uterus+3 more Frederic Amant 17
Not applicableUnknownNCT00601406What this trial is testingStudy of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerWho this might be right forBreast CancerCervical CancerEndometrial Cancer+7 more The Christie NHS Foundation Trust 2,200
Early research (Phase 1)Study completedNCT01652794What this trial is testingCarboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerWho this might be right forLeydig Cell TumorOvarian SarcomaOvarian Stromal Cancer+10 more Case Comprehensive Cancer Center 12